Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

West Haven, Connecticut 06516


Purpose:

Purpose: Phase I focus groups with clinicians and patients will gather qualitative data to focus and inform the content of Phase II. In Phase II, 12 weeks of psychotherapy will be offered to evaluate feasibility and potential efficacy of a couples-based, integrated treatment for men with PTSD and alcohol dependence. Hypotheses: We predict that this experimental psychotherapy, Partners Encouraging Abstinence and Coping with Emotions (PEACE), will reduce patient drinking, reduce PTSD symptoms, and improve relationship functioning.


Criteria:

Inclusion Criteria: - Male patients - One to six weeks of abstinence from alcohol and other drugs - Both partners agree to stated goals of abstinence from alcohol and drugs, reduction of PTSD symptoms, and relationship improvement - Current diagnoses of both alcohol dependence and PTSD - Receiving treatment for one or both disorders - Functionally able to participate in outpatient treatment as determined by P.I. "Functionally able" includes access to transportation. - Alcohol is "drug of choice" (History of other drugs acceptable) - Married or cohabiting in stable relationship for at least 6 months. Separated couples may participate if attempting to reconcile - Patient willing to sign release of information allowing researchers to communicate with patient's clinician regarding treatment goals Exclusion Criteria: - Spouse or partner also has an alcohol or drug problem as determined by P.I. based on report by patient or partner or as revealed on Alcohol Use Disorders Identification Test (AUDIT) or the Drug Abuse Screening Test (DAST) given to partner at intake assessment - Mental retardation or learning disorder by clinician report or patient chart - Psychotic disorder as determined by patient's chart or SCID - Patient currently receiving methadone or another opiate agonist by patient report or chart - Current fear of partner or history of severe domestic violence in the past year. An example of severe violence would be a couple reporting an episode of violence that required medical attention. Such couples will be excluded from the study and referred to domestic violence treatment. Couples who have experienced mild to moderate domestic violence may participate in Phase II of the study.


NCT ID:

NCT00622921


Primary Contact:

Principal Investigator
Ismene L Petrakis, MD
Yale University

Barbara C Moore, Ph.D.
Phone: 203-606-4767
Email: barbara.moore@yale.edu


Backup Contact:

Email: elizabeth.ralevski@yale.edu
Elizabeth Ralevski, Ph.D.
Phone: 203-932-5711 ext. 4282


Location Contact:

West Haven, Connecticut 06516
United States

Barbara Moore, Ph.D.
Phone: 203-606-4767
Email: barbara.moore@yale.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 20, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.